What are the terms of Jordan Montgomery's contract with the Rangers?
He signed a one-year, $1.25 million deal with performance bonuses.
Yanuki
ARTICLE DETAIL
Rangers Re-Sign Jordan Montgomery to Bolster Pitching Depth | Braves' Joey Wentz Out for Season with ACL Tear | Can Juan Soto Upset Ohtani for the 2026 NL MVP? | Ceddanne Rafaela Gains Experience and Insights at the World Baseball Classic | Harry Ford's Home Run and Royal Guard Celebration at the World Baseball Classic | Braves Stars Shine in 2026 World Baseball Classic | Joseph Contreras: Following in His Father's Footsteps to the MLB Draft | Byron Buxton's Place in Twins History: Analyzing His Legacy and Future | Pirates and Reds Exchange Tyler Callihan for Kyle Nicolas in Trade | Rangers Re-Sign Jordan Montgomery to Bolster Pitching Depth | Braves' Joey Wentz Out for Season with ACL Tear | Can Juan Soto Upset Ohtani for the 2026 NL MVP? | Ceddanne Rafaela Gains Experience and Insights at the World Baseball Classic | Harry Ford's Home Run and Royal Guard Celebration at the World Baseball Classic | Braves Stars Shine in 2026 World Baseball Classic | Joseph Contreras: Following in His Father's Footsteps to the MLB Draft | Byron Buxton's Place in Twins History: Analyzing His Legacy and Future | Pirates and Reds Exchange Tyler Callihan for Kyle Nicolas in Trade
MLB / Transactions
Rangers Re-Sign Jordan Montgomery to Bolster Pitching Depth
The Texas Rangers are bringing back a familiar face, re-signing left-handed pitcher Jordan Montgomery to a one-year, $1.25 million deal. This move aims to add depth to their pitching rotation as Montgomery recovers from Tommy John surgery.
Key Insights
- Jordan Montgomery returns to the Rangers on a one-year, $1.25 million contract with performance bonuses.
- Montgomery is recovering from Tommy John surgery and is expected to contribute in the second half of the 2026 season.
- He had a rough 2024 season with the Arizona Diamondbacks, posting a 6.23 ERA.
- Montgomery was a key part of the Rangers' 2023 World Series-winning team, recording a 2.79 ERA in 11 starts.
- Why this matters: The Rangers are strategically adding pitching depth with a proven performer who can provide valuable innings once healthy, reinforcing their chances for another playoff run.
In-Depth Analysis
Jordan Montgomery's return to the Rangers marks a low-risk, high-reward signing. After a stellar performance during the Rangers' 2023 World Series run, Montgomery struggled with the Diamondbacks in 2024 and missed the entire 2025 season due to Tommy John surgery.
However, the Rangers are banking on Montgomery's potential to regain his form. The one-year deal allows the team to assess his recovery and performance without a long-term commitment. If Montgomery can return to his pre-injury form, he could be a valuable asset to the Rangers' rotation, especially considering the injury histories of Nathan Eovaldi and Jacob deGrom.
The Rangers' rotation currently includes Eovaldi, deGrom, MacKenzie Gore, and Jack Leiter, with Jacob Latz and Kumar Rocker also in the mix. Montgomery's addition provides further competition and depth, ensuring the team is well-prepared for any potential setbacks.
FAQ
When is Montgomery expected to return from injury?
He is expected to be available in the second half of the 2026 season.
What role will Montgomery play on the team?
He is expected to provide rotation depth and compete for a starting spot once healthy.
Takeaways
- The Rangers are proactively addressing their pitching depth by bringing back Jordan Montgomery.
- Montgomery's return provides a potential boost to the rotation in the second half of the season.
- This move demonstrates the Rangers' commitment to contending for another World Series title.
Discussion
What are your expectations for Jordan Montgomery's return to the Rangers? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.